Zynerba Pharmaceuticals Probability of Future Stock Price Finishing Under 0.36
| ZYNEDelisted Stock | USD 0.36 0.01 2.70% |
Zynerba |
Zynerba Pharmaceuticals Target Price Odds to finish below 0.36
The tendency of Zynerba Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 0.36 | 90 days | 0.36 | about 66.36 |
Based on a normal probability distribution, the odds of Zynerba Pharmaceuticals to move below current price in 90 days from now is about 66.36 (This Zynerba Pharmaceuticals probability density function shows the probability of Zynerba Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.05 . This usually means Zynerba Pharmaceuticals market returns are highly-sensitive to returns on the market. As the market goes up or down, Zynerba Pharmaceuticals is expected to follow. Additionally Zynerba Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Zynerba Pharmaceuticals Price Density |
| Price |
Predictive Modules for Zynerba Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Zynerba Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Zynerba Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Zynerba Pharmaceuticals is not an exception. The market had few large corrections towards the Zynerba Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Zynerba Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Zynerba Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.21 | |
β | Beta against Dow Jones | 1.05 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | -0.05 |
Zynerba Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Zynerba Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Zynerba Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Zynerba Pharmaceuticals is not yet fully synchronised with the market data | |
| Zynerba Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Zynerba Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (35.04 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Zynerba Pharmaceuticals currently holds about 62.49 M in cash with (23.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.44, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Zynerba Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Zynerba Stock often depends not only on the future outlook of the current and potential Zynerba Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Zynerba Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 42.7 M | |
| Cash And Short Term Investments | 50.6 M |
Zynerba Pharmaceuticals Technical Analysis
Zynerba Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Zynerba Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Zynerba Pharmaceuticals. In general, you should focus on analyzing Zynerba Stock price patterns and their correlations with different microeconomic environments and drivers.
Zynerba Pharmaceuticals Predictive Forecast Models
Zynerba Pharmaceuticals' time-series forecasting models is one of many Zynerba Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Zynerba Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Zynerba Pharmaceuticals
Checking the ongoing alerts about Zynerba Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Zynerba Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Zynerba Pharmaceuticals is not yet fully synchronised with the market data | |
| Zynerba Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Zynerba Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (35.04 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Zynerba Pharmaceuticals currently holds about 62.49 M in cash with (23.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.44, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Zynerba Stock
If you are still planning to invest in Zynerba Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zynerba Pharmaceuticals' history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |